| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Gill David N is a Director at Evolus, Inc. with holdings across 3 companies. Recent SEC Form 4 filings include 4 buys and 2 sells.
Estimated insider holdings value: $601K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 14, 2024 | EOLS Evolus, Inc. | Director | Sell | 10,361 | $12.64 | $131,009.60 | -12.2% | +2.2% | -21.8% | |
| Aug 16, 2017 | OCGN Ocugen, Inc. | Director | Buy | 3,000 | $1.81 | $5,439.00 | +27.3% | - | - | |
| May 16, 2017 | OCGN Ocugen, Inc. | Director | Buy | 3,000 | $1.68 | $5,040.00 | +37.5% | - | - | |
| Dec 15, 2016 | OCGN Ocugen, Inc. | Director | Buy | 3,000 | $1.65 | $4,950.00 | +60.0% | - | - | |
| Dec 9, 2016 | OCGN Ocugen, Inc. | Director | Buy | 5,000 | $1.92 | $9,600.00 | New | - | - |